NCT05079360 2023-03-24
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Veru Inc.
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT00855114 2017-12-02
Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
Masonic Cancer Center, University of Minnesota
Phase 2 Withdrawn
NCT01163929 2012-10-24
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer
University of Kansas Medical Center
Phase 2 Withdrawn